| BCMA | B cell maturation antigen |
| CGH | Comparative genomic hybridization |
| CAN | Copy number abnormality |
| CAR | Chimeric antigen receptor |
| CI | Centrosome Index |
| CNV | Copy number variations |
| CTA | Cancer testis antigen |
| DEGs | Differentially expressed genes |
| DEMs | Differentially expressed miRNAs |
| FISH | Fluorescent in situ hybridization |
| GEP | Gene expression profiling |
| HR | High risk |
| HMCLs | Human myeloma cell lines |
| HY | Hyperdiploid cluster |
| IgH | Immunoglobulin heavy chain |
| LB | Low bone disease |
| miRNAs | MicroRNAs |
| M3CN | Molecular causal network |
| MGUS | Monoclonal gammopathy of unknown significance |
| MM | Multiple myeloma |
| NGS | Next-generation sequencing |
| NF-kB | Nuclear factor kappa light chain-enhancer |
| PAG | Proliferation-associated genes |
| PCs | Plasma cells |
| PCL | Plasma cell leukemia |
| PCR | Polymerase chain reaction |
| PI | Proteasome inhibitor |
| qRT-PCR | Quantitative real-time polymerase chain reaction |
| R-ISS | Revised International Staging System |
| RNASeq | RNA sequencing |
| RT-qPCR | Reverse transcriptase quantitative PCR |
| SAGE | Serial analysis of gene expression |
| SNP | Single nucleotide polymorphism |
| TWAS | Transcriptome-wide association study |